Tamibaro

Tamibaro Uses, Dosage, Side Effects, Food Interaction and all others data.

Tamibaro is a novel synthetic retinoid for acute promyelocytic leukaemia (APL). Tamibaro is currently approved in Japan for treatment of recurrent APL, and is undergoing clinical trials in the United States.

Tamibaro is a new synthetic retinoid drug recently approved for relapsed or refractory acute promyelocytic leukemia (APL) in Japan. It is a specific agonist for retinoic acid receptor alpha/beta. Compared to all-trans retinoic acid (ATRA), a natural retinoid indicated for a first-line treatment of APL, tamibarotene is chemically more stable and several times more potent as an inducer of differentiation in promyelocytic leukemia cells. In contrast to ATRA, whose plasma concentration declines considerably during daily administration, tamibarotene sustains plasma level probably due to a lower affinity for cellular retinoic acid binding protein. Furthermore, adverse side effects were milder than those of ATRA in clinical trials.

Trade Name Tamibaro
Generic Tamibarotene
Tamibarotene Other Names retinobenzoic acid, Tamibarotene
Type
Formula C22H25NO3
Weight Average: 351.4388
Monoisotopic: 351.183443671
Protein binding

Over 99%, predominantly to serum albumin.

Groups Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Tamibaro
Tamibaro

Uses

Investigated for use/treatment in leukemia (unspecified).

How Tamibaro works

Tamibaro is a specific agonist for retinoic acid receptor alpha/beta with possible binding to retinoid X receptors (RXR).

Innovators Monograph

You find simplified version here Tamibaro

*** Taking medicines without doctor's advice can cause long-term problems.
Share